A bench of justices A K Patnaik and Ranjan Gogoi on Monday agreed to hear the PIL after the petitioner, advocate M L Sharma pleaded for an urgent hearing in the case.
The case was earlier heard by a different vacation bench which had on June 10 asked Sharma to substantiate his ‘unfounded allegations’ that the Indian pharma major was allegedly manufacturing and selling adulterated medicines.
He, thereafter, filed an additional affidavit in
PIL against Ranbaxy: SC questions advocate
Regulator might inspect Wockhardt units
Ranbaxy drugs cleared FDA test before import alert
Supreme Court cancels 49 mining leases in Karnataka
PIL in Supreme Court for action against Ranbaxy